ישראל - עברית - Ministry of Health

alexion pharma israel ltd - eculizumab - תרכיז להכנת תמיסה לאינפוזיה - eculizumab 10 mg/ml - eculizumab - eculizumab - soliris is indicated for the treatment of patients with: - paroxysmal nocturnal hemoglobinuria ( pnh ).- atypical hemolytic uremic syndrome (ahus).

ישראל - עברית - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - brinzolamide; timolol as maleate - תרחיף לעין - timolol as maleate 5 mg / 1 ml; brinzolamide 10 mg / 1 ml - timolol, combinations

ישראל - עברית - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - emtricitabine; tenofovir disoproxil as fumarate - טבליות מצופות פילם - tenofovir disoproxil as fumarate 245 mg; emtricitabine 200 mg - tenofovir disoproxil and emtricitabine

ישראל - עברית - Ministry of Health

novo nordisk ltd., israel - estradiol as hemihydrate; norethisterone acetate - טבליות מצופות פילם - estradiol as hemihydrate 0.5 mg; norethisterone acetate 0.1 mg - estradiol, combinations - estradiol, combinations - eviana is indicated for women who have a uterus for the: treatment of moderate to severe vasomotor symptoms associated with menopause. prevention of postmenopausal osteoporosis. when prescribing solely for the prevention of postmenopausal osteoporosis therapy should only be considered for women at significant risk of osteoporosis and non-estrogen medications should be carefully considered.

ישראל - עברית - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - dorzolamide as hydrochloride - טיפות עיניים - dorzolamide as hydrochloride 20 mg/ml - dorzolamide

ישראל - עברית - Ministry of Health

k.s.kim international ltd - dabigatran etexilate - קפסולות - dabigatran etexilate 110 mg - dabigatran etexilate

ישראל - עברית - Ministry of Health

k.s.kim international ltd - dabigatran etexilate - קפסולות - dabigatran etexilate 150 mg - dabigatran etexilate

ישראל - עברית - Ministry of Health

takeda israel ltd - lanthanum as carbonate hydrate - טבליות לעיסות - lanthanum as carbonate hydrate 500 mg - lanthanum carbonate - lanthanum carbonate - fosrenol is indicated as a phosphate binding agent for use in the control of hyperphosphatemia in crf patients on haemodyalisis or continuous ambulatory peritoneal dialysis (capd).fosrenol is also indicated in adult patients with chronic kidney disease not on dialysis with serum phosphate levels > or = 1.78 mmol/l in whom a low phosphate diet alone is insufficient to control serum phosphate levels.

ישראל - עברית - Ministry of Health

takeda israel ltd - lanthanum as carbonate hydrate - טבליות לעיסות - lanthanum as carbonate hydrate 750 mg - lanthanum carbonate - lanthanum carbonate - fosrenol is indicated as a phosphate binding agent for use in the control of hyperphosphatemia in crf patients on haemodyalisis or continuous ambulatory peritoneal dialysis (capd).fosrenol is also indicated in adult patients with chronic kidney disease not on dialysis with serum phosphate levels > or = 1.78 mmol/l in whom a low phosphate diet alone is insufficient to control serum phosphate levels.

ישראל - עברית - Ministry of Health

takeda israel ltd - lanthanum as carbonate hydrate - טבליות לעיסות - lanthanum as carbonate hydrate 1000 mg - lanthanum carbonate - lanthanum carbonate - fosrenol is indicated as a phosphate binding agent for use in the control of hyperphosphatemia in crf patients on haemodyalisis or continuous ambulatory peritoneal dialysis (capd).fosrenol is also indicated in adult patients with chronic kidney disease not on dialysis with serum phosphate levels > or = 1.78 mmol/l in whom a low phosphate diet alone is insufficient to control serum phosphate levels.